Bloomington, March 12, 2023 (GLOBE NEWSWIRE) -- Bloomington, Minnesota -
Bloomington, MN based Chu Vision Institute recently published an article about the EVO ICL vision correction procedure. Those interested are invited to contact the office of Chu Vision Institute to schedule an appointment with Dr. Ralph Chu. They may also learn more about the procedure by reading the full article at the following link: EVO ICL Minneapolis.
Previously known as Visian ICL, EVO ICL is a permanent (yet removable) contact lens that is used to improve the patient’s vision. EVO ICL has many benefits, the clinic states, including clearer vision and UV sun protection. It can be used to treat astigmatism and nearsightedness, and it works even for those with a high prescription.
Many will already be familiar with the world’s most popular vision correction procedure, LASIK. However, not everyone is a suitable candidate for this procedure, and this may lead them to believe that they will have to continue using their glasses or contact lenses. Fortunately, this is far from the case, and a number of alternative vision correction treatments are now available for such candidates. Many (if not all) of these alternatives are available at Chu Vision Institute, and EVO ICL happens to be a strong contender for the clinic’s next most popular procedure.
The article explains that astigmatism, nearsightedness, thin corneas or a history of dry eye can make laser vision correction surgery unsuitable for a patient, but this may not be the case with EVO ICL. The article says, “Implantable contact lenses (ICLs), also known as phakic intraocular lens implants, can work as a solution for these patients and provide significant vision improvement. The EVO ICL is implanted in front of the natural crystalline lens of the eye, behind the cornea and iris, and works to provide clear vision for patients with moderate to severe myopia (nearsightedness). Like LASIK, this implanted lens is meant to be a permanent or long-term solution. While they function quite similarly to contacts, the fact that they are implanted inside the eye makes them far more convenient to use.
Chu Vision Institute says EVO ICL may to be the answer if a patient has a high degree of myopia (nearsightedness) or moderate myopic astigmatism but does not qualify for other kinds of refractive surgery. Dr. Chu looks for patients who are healthy overall, are between the ages of 21 to 45 and have had a stable eye prescription. However, all patients are required to undergo a thorough eye exam and assessment to determine their candidacy. During this appointment, they are also welcome to ask any questions about the procedure and what they may expect.